Open Medicine EU

Archives for

The European Medicines Agency announced today (30th November) a new transparency policy that would widen access to documents held by the agency. This is good news (apart from the fact that I had to scrap a post I had just finished, attacking the old policy…) I believe that the agency will be more transparent under… » read more

Posted by Jim Murray

AstraZeneca on Transparency

Interesting report on FoxBusiness News ( I know, I know). The global pharmaceuticals industry must become more transparent if it is to rebuild public trust in the sector, AstraZeneca PLC’s chief executive said Wednesday. David Brennan told a gathering of drug sector leaders that industry stockholders need to collaborate to collectively address the world’s healthcare… » read more

Posted by Jim Murray

Prequel to Seroquel

How is science made in a pharmaceutical company, when billions of Euros may depend on the outcome of a scientific experiment? A partial, if incomplete, glimpse at the process can be seen in the documents released last year in a court case in the US on the AstraZeneca medicine Seroquel. (Seroquel is a “blockbuster” drug,… » read more

Posted by Jim Murray